RAIRDA launches fourth vaccination dose survey

RAIRDA and its member charities have launched a short survey aimed at all adults with a rheumatic condition in the UK. We want to understand whether those who are eligible have been able to access a fourth dose of the coronavirus (COVID-19) vaccine as part of their COVID-19 vaccination schedule as well as gain insights on other important issues related to COVID-19.

To be clear this ‘fourth dose’ is a ‘booster’ dose. You can get a booster (4th dose) from 3 months (91 days) after your 3rd primary dose. Eligibility criteria for the third and fourth dose of the COVID-19 vaccine can be found via the following link: https://bit.ly/3D0m6KR

Please only complete the survey if you have a rheumatic condition AND believe yourself to be eligible for a third/fourth dose of the COVID-19 vaccine.

Examples of rheumatic conditions include:

  • Forms of connective tissue disease (for example: lupus, Sjogren’s Syndrome, scleroderma)
  • Form of systemic vasculitis (For example: Behcet’s or types of ANCA Vasculitis like GPA)
  • Giant Cell Arteritis
  • Rheumatoid arthritis
  • Psoriatic arthritis
  • Axial spondyloarthritis (including ankylosing spondyloarthritis)
  • Polymyalgia Rheumatica

This survey will close on midnight Thursday 7th April 2022.